Early bioavailability of inhaled salbutamol reflects lung dose in children.
作者信息
Bønnelykke Klaus, Jespersen Jacob J, Bisgaard Hans
出版信息
Br J Clin Pharmacol. 2008 Oct;66(4):562-3. doi: 10.1111/j.1365-2125.2008.03195.x. Epub 2008 Apr 10.
Abstract
摘要
相似文献
1
Early bioavailability of inhaled salbutamol reflects lung dose in children.吸入沙丁胺醇的早期生物利用度反映儿童肺部剂量。
Br J Clin Pharmacol. 2008 Oct;66(4):562-3. doi: 10.1111/j.1365-2125.2008.03195.x. Epub 2008 Apr 10.
2
Comparative pharmacokinetics of salbutamol inhaled from a pressurized metered dose inhaler either alone or connected to a newly enhanced spacer design.沙丁胺醇单独经压力定量气雾剂吸入和经新增强化贮雾器连接吸入的比较药代动力学。
Eur J Pharm Sci. 2020 Apr 30;147:105304. doi: 10.1016/j.ejps.2020.105304. Epub 2020 Mar 9.
3
Small airway bronchodilator response to different doses of salbutamol in 7-year-old children.7 岁儿童不同剂量沙丁胺醇对小气道支气管扩张的反应。
Respir Res. 2017 Aug 3;18(1):148. doi: 10.1186/s12931-017-0632-8.
4
Age dependent systemic exposure to inhaled salbutamol.年龄依赖性的吸入沙丁胺醇的全身暴露量。
Br J Clin Pharmacol. 2007 Aug;64(2):241-4. doi: 10.1111/j.1365-2125.2007.02868.x. Epub 2007 Mar 1.
5
Bioavailability Study of Niosomal Salbutamol Sulfate in Metered Dose Inhaler: Controlled Pulmonary Drug Delivery.硫酸沙丁胺醇脂质体定量吸入器的生物利用度研究：可控肺部药物递送
J Aerosol Med Pulm Drug Deliv. 2018 Apr;31(2):114-115. doi: 10.1089/jamp.2017.1448. Epub 2018 Feb 16.
6
Effects of airway calibre on lung delivery of nebulised salbutamol.气道口径对雾化沙丁胺醇肺部给药的影响。
Thorax. 1997 Dec;52(12):1036-9. doi: 10.1136/thx.52.12.1036.
7
Performance of Large Spacer Versus Nebulizer T-Piece in Single-Limb Noninvasive Ventilation.大容积活瓣与射流雾化器 T 型管在单肢无创通气中的比较。
Respir Care. 2018 Nov;63(11):1360-1369. doi: 10.4187/respcare.05976. Epub 2018 Aug 7.
8
Physiologically Based Pharmacokinetic/Pharmacodynamic Modeling Accurately Predicts the Better Bronchodilatory Effect of Inhaled Versus Oral Salbutamol Dosage Forms.生理基于药代动力学/药效动力学模型准确预测吸入与口服沙丁胺醇剂型的更好支气管扩张作用。
J Aerosol Med Pulm Drug Deliv. 2019 Feb;32(1):1-12. doi: 10.1089/jamp.2017.1436. Epub 2018 Jun 7.
9
Relative bioavailability of salbutamol to the lung following inhalation when administration is prolonged.给药时间延长时，吸入沙丁胺醇后对肺部的相对生物利用度。
Br J Clin Pharmacol. 2000 Sep;50(3):281-4. doi: 10.1046/j.1365-2125.2000.00255.x.
10
Comparison of nebulized ipratropium bromide with salbutamol vs salbutamol alone in acute asthma exacerbation in children.雾化吸入异丙托溴铵联合沙丁胺醇与单用沙丁胺醇治疗儿童急性哮喘加重期的比较。
Ann Allergy Asthma Immunol. 2006 May;96(5):701-6. doi: 10.1016/S1081-1206(10)61068-X.
引用本文的文献
1
Evaluation of Preliminary Bronchodilation Effect on Aerosol Delivery from a Dry Powder Inhaler for Patients with Chronic Obstructive Pulmonary Disease with Suboptimal Peak Inspiratory Flow Rate.对吸气峰流速未达最佳的慢性阻塞性肺疾病患者，评估干粉吸入器气溶胶递送的初步支气管扩张效果。
Clin Pharmacokinet. 2025 Aug 29. doi: 10.1007/s40262-025-01560-x.
本文引用的文献
1
Age dependent systemic exposure to inhaled salbutamol.年龄依赖性的吸入沙丁胺醇的全身暴露量。
Br J Clin Pharmacol. 2007 Aug;64(2):241-4. doi: 10.1111/j.1365-2125.2007.02868.x. Epub 2007 Mar 1.
2
Delivery of inhaled medication to children.向儿童递送吸入药物。
J Asthma. 1997;34(6):443-67. doi: 10.3109/02770909709055389.
3
Pharmacokinetics of inhaled drugs.吸入药物的药代动力学。
Br J Clin Pharmacol. 1996 Dec;42(6):697-705. doi: 10.1046/j.1365-2125.1996.00493.x.
4
A non-electrostatic spacer for aerosol delivery.一种用于气雾剂递送的非静电间隔物。
Arch Dis Child. 1995 Sep;73(3):226-30. doi: 10.1136/adc.73.3.226.
5
Pharmacokinetics, efficacy and adverse effects of sublingual salbutamol in patients with asthma.
Eur J Clin Pharmacol. 1989;37(6):567-71. doi: 10.1007/BF00562546.
6
Determination of the relative bioavailability of salbutamol to the lung following inhalation.吸入后沙丁胺醇在肺部的相对生物利用度的测定。
Br J Clin Pharmacol. 1992 Oct;34(4):311-5. doi: 10.1111/j.1365-2125.1992.tb05921.x.
Zotero 插件